title: Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B).
abstract: Phosphodiesterase-4 (PDE4), an enzyme that catalyzes the hydrolysis of cyclic AMP and plays a critical role in controlling its intracellular concentration, has been implicated in depression- and anxiety-like behaviors. However, the functions of the four PDE4 subfamilies (PDE4A, PDE4B, PDE4C, and PDE4D) remain largely unknown. In animal tests sensitive to anxiolytics, antidepressants, memory enhancers, or analgesics, we examined the behavioral phenotype of mice deficient in PDE4B (PDE4B-/-). Immunoblot analysis revealed loss of PDE4B expression in the cerebral cortex and amygdala of PDE4B-/- mice. The reduction of PDE4B expression was accompanied by decreases in PDE4 activity in the brain regions of PDE4B-/- mice. Compared to PDE4B+/+ littermates, PDE4B-/- mice displayed anxiogenic-like behavior, as evidenced by decreased head-dips and time spent in head-dipping in the holeboard test, reduced transitions and time on the light side in the light-dark transition test, and decreased initial exploration and rears in the open-field test. Consistent with anxiogenic-like behavior, PDE4B-/- mice displayed increased levels of plasma corticosterone. In addition, these mice also showed a modest increase in the proliferation of neuronal cells in the hippocampal dentate gyrus. In the forced-swim test, PDE4B-/- mice exhibited decreased immobility; however, this was not supported by the results from the tail-suspension test. PDE4B-/- mice did not display changes in memory, locomotor activity, or nociceptive responses. Taken together, these results suggest that the PDE4B subfamily is involved in signaling pathways that contribute to anxiogenic-like effects on behavior.
authors: Department of Behavioral Medicine and Psychiatry, West Virginia University Health Sciences Center, Morgantown, WV 26506, USA. hzhang@hsc.wvu.edu
authors: Han-Ting
authors: HT
authors: Zhang
authors: Ying
authors: Y
authors: Huang
authors: Anbrin
authors: A
authors: Masood
authors: Lisa R
authors: LR
authors: Stolinski
authors: Yunfeng
authors: Y
authors: Li
authors: Lei
authors: L
authors: Zhang
authors: Daniel
authors: D
authors: Dlaboga
authors: S-L Catherine
authors: SL
authors: Jin
authors: Marco
authors: M
authors: Conti
authors: James M
authors: JM
authors: O'Donnell
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001007:Anxiety / Q000097:blood / Q000235:genetics* / Q000473:pathology / Q000503:physiopathology*; D001362:Avoidance Learning; D001522:Behavior, Animal; D001921:Brain / Q000473:pathology / Q000503:physiopathology; D001973:Bromodeoxyuridine / Q000378:metabolism; D049109:Cell Proliferation; D003345:Corticosterone / Q000097:blood; D054703:Cyclic Nucleotide Phosphodiesterases, Type 4 / Q000172:deficiency* / Q000378:metabolism; D004195:Disease Models, Animal; D005106:Exploratory Behavior; D005786:Gene Expression Regulation / Q000502:physiology; D019417:Hindlimb Suspension; D008297:Male; D008568:Memory; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009043:Motor Activity; D010641:Phenotype; D011930:Reaction Time
chemical_list: D054703:Cyclic Nucleotide Phosphodiesterases, Type 4; D001973:Bromodeoxyuridine; D003345:Corticosterone
references: Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):15020-5
references: 9844008
references: J Neurosci. 1999 Jan 15;19(2):610-8
references: 9880581
references: J Comp Neurol. 1999 May 3;407(2):287-301
references: 10213096
references: Pharmacol Biochem Behav. 1999 Sep;64(1):1-5
references: 10494990
references: J Psychopharmacol. 1999;13(3):274-7
references: 10512083
references: Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):11998-2003
references: 10518565
references: J Immunol. 2004 Dec 15;173(12):7531-8
references: 15585880
references: Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):3034-9
references: 15718284
references: Curr Opin Cell Biol. 2005 Apr;17(2):129-34
references: 15780588
references: Psychopharmacology (Berl). 2005 May;179(3):613-9
references: 15672274
references: Neurosci Biobehav Rev. 2005;29(4-5):571-625
references: 15890404
references: Biochem J. 2005 Jun 15;388(Pt 3):803-11
references: 15717866
references: Methods Mol Biol. 2005;307:191-210
references: 15988065
references: J Immunol. 2005 Aug 1;175(3):1523-31
references: 16034090
references: J Biol Chem. 2005 Sep 30;280(39):33178-89
references: 16030021
references: J Clin Invest. 2005 Oct;115(10):2697-9
references: 16200206
references: Cell. 2005 Oct 7;123(1):25-35
references: 16213210
references: Drug Discov Today. 2005 Nov 15;10(22):1503-19
references: 16257373
references: Crit Rev Neurobiol. 1996;10(3-4):419-46
references: 8978989
references: Eur J Pharmacol. 1997 Mar 5;321(3):273-8
references: 9085037
references: Br J Pharmacol. 1997 Jun;121(3):459-68
references: 9179387
references: Eur J Pharmacol. 1997 Jun 5;328(1):9-18
references: 9203561
references: Science. 2005 Nov 18;310(5751):1187-91
references: 16293762
references: Hippocampus. 2006;16(3):239-49
references: 16425236
references: Pharmacol Rep. 2006 Jan-Feb;58(1):115-9
references: 16531638
references: Circ Res. 2006 Mar 17;98(5):582-4
references: 16543507
references: Psychopharmacology (Berl). 2006 Jun;186(2):209-17
references: 16586089
references: Life Sci. 2006 May 30;79(1):81-8
references: 16458932
references: Proc Natl Acad Sci U S A. 2006 May 23;103(21):8233-8
references: 16702546
references: Biol Psychiatry. 2006 Jun 15;59(12):1136-43
references: 16797263
references: Brain Res. 2006 Jun 22;1096(1):104-12
references: 16730340
references: Stroke. 2006 Aug;37(8):2012-7
references: 16825591
references: Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13208-13
references: 16924103
references: J Cell Biol. 2006 Nov 6;175(3):441-51
references: 17088426
references: Biol Psychiatry. 2007 Jan 1;61(1):56-64
references: 16814262
references: Am J Physiol Cell Physiol. 2007 Jan;292(1):C319-31
references: 16899551
references: Neuron. 2007 May 3;54(3):387-402
references: 17481393
references: J Pharmacol Exp Ther. 2007 Aug;322(2):600-9
references: 17519386
references: Psychopharmacology (Berl). 2007 Jun;192(3):415-24
references: 17333137
references: Eur J Pharmacol. 1999 Oct 27;383(2):95-106
references: 10585522
references: Pharmacol Biochem Behav. 2000 Jan 1;65(1):7-13
references: 10638629
references: J Neurochem. 2000 Mar;74(3):1257-62
references: 10693959
references: Brain Res. 2000 Apr 7;861(1):117-25
references: 10751571
references: Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6751-6
references: 10841571
references: Neuropsychopharmacology. 2000 Aug;23(2):198-204
references: 10882846
references: Synapse. 2000 Aug;37(2):159-62
references: 10881036
references: Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10272-6
references: 10954756
references: Eur J Pharmacol. 2000 Sep 29;405(1-3):397-406
references: 11033344
references: Eur Neuropsychopharmacol. 2000 Dec;10(6):473-81
references: 11115737
references: J Neurosci. 2000 Dec 15;20(24):9040-5
references: 11124980
references: J Neurosci. 2000 Dec 15;20(24):9104-10
references: 11124987
references: Indian J Exp Biol. 2000 Jan;38(1):26-30
references: 11233080
references: Physiol Behav. 2000 Dec;71(5):517-23
references: 11239670
references: J Chem Neuroanat. 2000 Dec;20(3-4):349-74
references: 11207431
references: Biochim Biophys Acta. 2001 Mar 19;1518(1-2):27-35
references: 11267656
references: J Pharmacol Exp Ther. 2001 Nov;299(2):401-7
references: 11602648
references: J Neurosci. 2002 May 1;22(9):3673-82
references: 11978843
references: Neuropsychopharmacology. 2002 Oct;27(4):587-95
references: 12377395
references: Neuropharmacology. 2002 Dec;43(7):1148-57
references: 12504921
references: J Biol Chem. 2003 Feb 21;278(8):5493-6
references: 12493749
references: Biochem J. 2003 Mar 1;370(Pt 2):429-38
references: 12441002
references: Science. 2003 Aug 8;301(5634):805-9
references: 12907793
references: Neuropsychopharmacology. 2003 Sep;28(9):1562-71
references: 12838272
references: Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10518-22
references: 12930888
references: Nat Genet. 2003 Oct;35(2):131-8
references: 14517540
references: Trends Pharmacol Sci. 2004 Mar;25(3):158-63
references: 15019272
references: Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9468-73
references: 15192151
references: Neuropsychopharmacology. 2004 Aug;29(8):1432-9
references: 15114341
references: Science. 1972 Apr 28;176(4033):428-30
references: 4402069
references: Pharmacol Biochem Behav. 1981 Sep;15(3):501-4
references: 7291252
references: Methods Find Exp Clin Pharmacol. 1986 Sep;8(9):557-65
references: 2877126
references: Behav Neural Biol. 1990 Mar;53(2):153-9
references: 2158780
references: Pharmacol Biochem Behav. 1991 Jun;39(2):321-3
references: 1658815
references: Mol Cell Biol. 1993 Oct;13(10):6558-71
references: 8413254
references: Eur Neuropsychopharmacol. 1993 Dec;3(4):477-84
references: 8111220
references: Gene. 1994 Nov 18;149(2):237-44
references: 7958996
references: Methods Find Exp Clin Pharmacol. 1994 Dec;16(10):717-21
references: 7723470
references: Eur J Pharmacol. 1995 Nov 24;286(3):281-90
references: 8608790
references: Pharmacol Biochem Behav. 1997 Nov;58(3):737-46
references: 9329067
references: J Psychiatr Res. 1997 Jul-Aug;31(4):393-432
references: 9352470
references: Braz J Med Biol Res. 1997 Aug;30(8):967-70
references: 9361726
references: Biochem J. 1997 Dec 1;328 ( Pt 2):549-58
references: 9371714
references: Biol Psychiatry. 1998 Mar 1;43(5):389-91
references: 9513755
references: Pharmacol Biochem Behav. 1998 Jul;60(3):645-53
references: 9678648
references: J Pineal Res. 1998 Aug;25(1):34-40
references: 9694402
references: Neuropsychopharmacology. 1998 Nov;19(5):381-96
references: 9778660